ARROWHEAD PHARMACEUTICALS IN (ARWR)
US04280A1007 - Common Stock
| 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -609.69M | -209.30M | -176.50M | -140.80M | -84.60M | |||
| Depreciation Amortization | 18.59M | 12.50M | 10.40M | 8.30M | 5.90M | |||
| Change In Working Capital | 25.09M | -51.50M | -98.30M | 226.90M | -60.70M | |||
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Taxes Paid | 3.74M | 0.00 | 0.00 | 0.00 | -100.00K | |||
| Other non cash items | 103.16M | 94.40M | 128.20M | 76.90M | 43.90M | |||
| OPERATING CASH FLOW | -462.85M | -153.90M | -136.10M | 171.20M | -95.40M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -141.47M | -176.70M | -52.80M | -23.60M | -12.00M | |||
| Other Investing Activity | -278.60M | 80.60M | 47.40M | -118.10M | -228.80M | |||
| INVESTING CASH FLOW | -420.07M | -96.20M | -5.40M | -141.70M | -240.80M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 442.00M | 250.00M | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 431.65M | 3.10M | 5.20M | 11.30M | 257.90M | |||
| Other Financing Activity | -3.13M | 0.00 | 60.00M | N/A | 0.00 | |||
| FINANCING CASH FLOW | 870.52M | 253.10M | 65.20M | 11.30M | 257.90M | |||
| Exchange Rate Effect | 4.20M | -100.00K | -100.00K | N/A | N/A | |||
| CHANGE IN CASH | -8.21M | 2.90M | -76.40M | 40.80M | -78.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -462.85M | -153.90M | -136.10M | 171.20M | -95.40M | |||
| Capital Expenditure | -141.47M | -176.70M | -52.80M | -23.60M | -12.00M | |||
| FREE CASH FLOW | -604.32M | -330.60M | -188.90M | 147.60M | -107.40M | |||
All data in USD